Oct 27, 2022 / 09:30AM GMT
Presentation
Oct 27, 2022 / 09:30AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Director of IR
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Giles Platford
Takeda Pharmaceutical Company Limited - President of the Plasma-Derived Therapies Business Unit
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Masato Iwasaki
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
* Teresa Bitetti
Takeda Pharmaceutical Company Limited - President of the Global Oncology Business Unit
=====================
Takeda Pharmaceutical Co Ltd
(OTCPK:TKPHF)
$
35.89
+0.95 (+2.72%)
Market Cap: 54.95 Bil
Enterprise Value: 82.50 Bil
PE Ratio: 0
PB Ratio: 1.15
GF Score: 77/100 Q2 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 27, 2022 / 09:30AM GMT
Release Date Price:
$25.72
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot